Terms: = Prostate cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Staging
5 results:
1. Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.
Hou Y; Jiang KW; Wang LL; Zhi R; Bao ML; Li Q; Zhang J; Qu JR; Zhu FP; Zhang YD
Br J Cancer; 2023 Nov; 129(10):1625-1633. PubMed ID: 37758837
[TBL] [Abstract] [Full Text] [Related]
2. A circadian rhythm-related gene signature for predicting relapse risk and immunotherapeutic effect in prostate adenocarcinoma.
Liu J; Tan Z; Yang S; Song X; Li W
Aging (Albany NY); 2022 Sep; 14(17):7170-7185. PubMed ID: 36103249
[TBL] [Abstract] [Full Text] [Related]
3. Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer.
Schilling D; Boekeler U; Gakis G; Schwentner C; Corvin S; Sotlar K; Müller AC; Bares R; Stenzl A
World J Urol; 2010 Dec; 28(6):715-20. PubMed ID: 20349074
[TBL] [Abstract] [Full Text] [Related]
4. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
[TBL] [Abstract] [Full Text] [Related]
5. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.
Burkhard FC; Bader P; Schneider E; Markwalder R; Studer UE
Eur Urol; 2002 Aug; 42(2):84-90; discussion 90-2. PubMed ID: 12160577
[TBL] [Abstract] [Full Text] [Related]
